Trials / Conditions / Glioblastoma, Adult

Glioblastoma, Adult

20 registered clinical trials studyying Glioblastoma, Adult — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors NCT06902350	Chipscreen Biosciences, Ltd.	Phase 1
Not Yet Recruiting	CSF Proteomic Characterization of Glioblastomas NCT06845020	Univeridad Autonoma de Guadalajara	—
Recruiting	Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study NCT06954636	Sied Kebir	—
Terminated	Function and Composition of Regulatory B Cells in Participants With Glioblastoma NCT04128774	Amsterdam UMC, location VUmc	—
Completed	First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblast NCT04116658	Enterome	Phase 1 / Phase 2
Completed	Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9 NCT03744026	CarThera	Phase 1 / Phase 2
Completed	Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma NCT03665545	University Hospital, Geneva	Phase 1 / Phase 2
Terminated	DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma NCT03714334	Clinica Universidad de Navarra, Universidad de Navarra	Phase 1
Unknown	A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme NCT03025893	Amsterdam UMC, location VUmc	Phase 2 / Phase 3
Completed	Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma NCT03522298	Kazia Therapeutics Limited	Phase 2
Completed	NCT Neuro Master Match - N²M² (NOA-20) NCT03158389	University Hospital Heidelberg	Phase 1 / Phase 2
Completed	GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification NCT03618667	Samsung Medical Center	Phase 2
Active Not Recruiting	Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) NCT03277638	Case Comprehensive Cancer Center	Phase 1 / Phase 2
Completed	Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME) NCT03291977	Rennes University Hospital	Phase 3
Completed	NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma NCT03232424	Hackensack Meridian Health	Phase 1
Recruiting	Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM NCT03213002	Northwell Health	Phase 1 / Phase 2
Active Not Recruiting	Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas NCT03181477	Centre Georges Francois Leclerc	N/A
Completed	Ketogenic Diets as an Adjuvant Therapy in Glioblastoma NCT03075514	University of Liverpool	N/A
Active Not Recruiting	A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) NCT02974738	Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 1
Completed	Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas. NCT04610229	Azienda USL Reggio Emilia - IRCCS	N/A